UBS Call 95 ABL 19.09.2025/ DE000UM6JKE8 /
15/11/2024 19:39:52 | Diferencia+0.040 | Bid21:56:18 | Ask21:56:18 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
2.420EUR | +1.68% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
ABBOTT LABS | 95.00 - | 19/09/2025 | Call |
GlobeNewswire
06/08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página